Logo-ajmb

Read This Article

Article History

Submitted: 22 Feb 2025
Accepted: 22 Apr 2025
ePublished: 31 Oct 2025

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

Avicenna J Med Biochem. 2025;13(1): 71-72.
doi: 10.34172/ajmb.2600
  Abstract View: 126
  PDF Download: 13

Letter to Editor

Elabela: A Novel Biomarker and Therapeutic Target in Diabetic Kidney Disease

Roshan Kumar Mahat 1* ORCID logo

1 Department of Biochemistry, Teerthanker Mahaveer Medical College & Research Centre, Teerthanker Mahaveer University, Moradabad, India
*Corresponding Author: Roshan Kumar Mahat, Email: mahatroshan79@gmail.com
Please cite this article as follows: Mahat RK. Elabela: a novel biomarker and therapeutic target in diabetic kidney disease. Avicenna J Med Biochem. 2024;13(1):71-72. doi:10.34172/ajmb.2600
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 127

Your browser does not support the canvas element.

PDF Download: 13

Your browser does not support the canvas element.